Nutrien - NTR Stock Forecast, Price & News

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last twelve months. There are currently 1 sell rating, 8 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" NTR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NTR, but not buy additional shares or sell existing shares.
View NTR analyst ratings or view top-rated stocks.

17 analysts have issued 1-year price targets for Nutrien's shares. Their NTR share price forecasts range from $65.00 to $121.00. On average, they anticipate the company's share price to reach $97.78 in the next twelve months. This suggests a possible upside of 18.2% from the stock's current price.
View analysts price targets for NTR or view top-rated stocks among Wall Street analysts.

Nutrien's stock was trading at $73.03 at the beginning of 2023. Since then, NTR stock has increased by 13.3% and is now trading at $82.71.
View the best growth stocks for 2023 here.

Nutrien saw a drop in short interest in January. As of January 15th, there was short interest totaling 6,110,000 shares, a drop of 24.0% from the December 31st total of 8,040,000 shares. Based on an average trading volume of 2,140,000 shares, the days-to-cover ratio is presently 2.9 days. Approximately 1.2% of the company's stock are short sold.
View Nutrien's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 15th 2023.
View our NTR earnings forecast.

Nutrien will be holding an earnings conference call on Thursday, February 16th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 877-674-7070 with passcode "345556".

Nutrien Ltd. (NYSE:NTR) announced its quarterly earnings results on Monday, November, 1st. The company reported $1.38 earnings per share for the quarter, beating the consensus estimate of $1.23 by $0.15. The company had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $5.59 billion. Nutrien had a trailing twelve-month return on equity of 29.68% and a net margin of 20.60%. The firm's revenue was up 42.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.23 EPS.

Nutrien announced a quarterly dividend on Thursday, November 3rd. Stockholders of record on Friday, December 30th will be paid a dividend of $0.48 per share on Friday, January 13th. This represents a $1.92 annualized dividend and a dividend yield of 2.32%. The ex-dividend date is Thursday, December 29th.
Read our dividend analysis for NTR.

Nutrien (NYSE:NTR) pays an annual dividend of $1.92 per share and currently has a dividend yield of 2.31%. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 13.67%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, NTR will have a dividend payout ratio of 16.55% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for NTR.

Nutrien issued an update on its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share (EPS) guidance of $13.25-$14.50 for the period, compared to the consensus earnings per share estimate of $16.55. The company issued revenue guidance of -.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC), CVS Health (CVS), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by many different institutional and retail investors. Top institutional shareholders include National Bank of Canada FI (0.77%), Sumitomo Mitsui Trust Holdings Inc. (0.36%), DekaBank Deutsche Girozentrale (0.35%), Bank of Montreal Can (0.00%), Addenda Capital Inc. (0.16%) and GMT Capital Corp (0.13%).

Shares of NTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NTR stock can currently be purchased for approximately $82.71.

Nutrien (NYSE:NTR) has a market capitalization of $42.01 billion and generates $27.71 billion in revenue each year. The company earns $3.15 billion in net income (profit) each year or $14.05 on an earnings per share basis.

The company employs 23,500 workers across the globe.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The official website for the company is www.nutrien.com. The company can be reached via phone at (800) 667-0403, via email at investors@nutrien.com, or via fax at 306-933-8877.